Join the Revatio group to help and get support from people like you.
Revatio News
Viagra, Cialis Plus a Heart Med Could Be a Dangerous Combo
MONDAY, Jan. 15, 2024 – Taking nitrates for heart problems alongside erectile dysfunction drugs like Viagra or Cialis could be a prescription for trouble, a new study warns. Men who combine the two...
Erectile Troubles in Middle Age a Bad Sign for Men's Brains
FRIDAY, June 2, 2023 – Erectile dysfunction (ED) has been tied to an increased risk of diabetes, high blood pressure and heart disease. Now, research suggests that erectile woes during late middle...
FDA Medwatch Alert: AvKARE Issues Voluntary Nationwide Recall of Sildenafil 100mg Tablets and Trazodone 100mg Tablets Due to Product Mix-Up
December 9, 2020 – AvKARE, Pulaski, TN is voluntarily recalling one lot of Sildenafil 100 mg tablets and one lot of Trazodone 100mg tablets to the consumer level. These products have been recalled...
FDA Medwatch Alert: Dietary Supplements for Male Sexual Enhancement by A and H Focal: Recall - Undeclared Drug Ingredient
[Posted 03/07/2017] ISSUE: A&H Focal Inc. is voluntarily recalling all lots marketed as dietary supplements for male sexual enhancement from January 2014 to present. These products have been...
FDA Medwatch Alert: Revatio (sildenafil): Drug Safety Communication - FDA Clarifies Warning About Pediatric Use for Pulmonary Arterial Hypertension
ISSUE: FDA is clarifying its previous recommendation related to prescribing Revatio (sildenafil) for children with pulmonary arterial hypertension (PAH). Revatio is FDA-approved only to treat PAH in...
FDA Medwatch Alert: Silver Sword and Clalis by hardmenstore.com: Recall - Undeclared Drug Ingredient
ISSUE: Hardmenstore.com recalled 430 lots of Silver Sword and Clalis at the consumer level. Silver Sword and Clalis have been found to contain Sildenafil, which could cause adverse reactions and drug...
FDA Medwatch Alert: Lightning Rod Capsules: Recall - Undeclared Drug Ingredient
ISSUE: Chang Kwung announced today that it is conducting a voluntary nationwide recall of the company’s dietary supplements sold under the brand name Lightning Rod (500 mg per capsule packaged in 3...
FDA Medwatch Alert: American Lifestyle Vicerex and Black Ant Capsules: Recall - Undeclared Drug Ingredient
ISSUE: May 1, 2013 - American Lifestyle is announcing that it is conducting a voluntary recall of all lots of Vicerex UPC 893490820087 and Black Ant UPC 4026666142546. Laboratory analysis conducted...
FDA Medwatch Alert: Affirm XL Recall - Undeclared Drug Ingredient
ISSUE: Affirm XL, Inc. is conducting a voluntary recall to the consumer level after FDA lab analysis testing found the product to contain an analogue of sildenafil. Sildenafil is an active ingredient...
FDA Medwatch Alert: ROCK-It MAN Male Enhancement Capsules: Recall - Undeclared Drug Ingredient
ISSUE: Consumer Concepts, Inc. notified the public of a consumer/user level recall of all ROCK-It MAN Male Enhancement Capsules sold between October, 2012 and April, 2013. Analytical tests conducted...
FDA Medwatch Alert: Night Bullet: Recall - Undeclared Drug Ingredient
ISSUE: Green Planet, Inc. notified the public of a recall of its dietary supplement product Night Bullet. Analytical tests conducted by the FDA found that the product contains trace amounts of...
FDA Medwatch Alert: Mojo Nights and Mojo Nights for Her: Recall - Undeclared Drug Ingredient
ISSUE: Evol Nutrition Associates, Inc./Red Dawn (“Evol Nutrition”) notified the public of a nationwide recall of all lots of two dietary supplement products distributed by the company under the names ...
FDA Medwatch Alert: Revatio (sildenafil): Drug Safety Communication - Recommendation Against Use in Children
ISSUE: FDA notified healthcare professionals and their medical care organizations that Revatio (sildenafil) should not be prescribed to children (ages 1 through 17) for pulmonary arterial...
FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations NEW YORK--(BUSINESS WIRE)--Nov 20, 2009 - Pfizer announced today that the U.S. Food and Drug Administration...
FDA Medwatch Alert: Revatio (sildenafil)
[Posted 10/18/2007] FDA informed healthcare professionals of reports of sudden decreases or loss of hearing following the use of PDE5 inhibitors Viagra, Levitra, Cialis for the treatment of erectile...
Ask a question
To post your own question to this support group, sign in or create an account.